EarlySight is a Swiss startup company focused on reducing vision-loss by enabling earlier detection and better monitoring of eye degenerative diseases.
The company was founded in March 2019 as a spinoff of the Swiss Federal Institute of Technology in Lausanne (EPFL). It uses a novel approach to provide a single cell level imaging of the back of the eye, called the retina.
The eye imaging device in development observes the cells affected at early-stage of the most prevalent retinal diseases such as age-related macular degeneration, glaucoma, or diabetic retinopathy, with the expected goal to enable earlier diagnoses and more efficient treatments.
The company was founded in March 2019 as a spinoff of the Swiss Federal Institute of Technology in Lausanne (EPFL). It uses a novel approach to provide a single cell level imaging of the back of the eye, called the retina.
The eye imaging device in development observes the cells affected at early-stage of the most prevalent retinal diseases such as age-related macular degeneration, glaucoma, or diabetic retinopathy, with the expected goal to enable earlier diagnoses and more efficient treatments.
Informations clés
- Technique médicale
- Avenue de Sécheron 15, 1202 Genève
- EarlySight SA
De nouveaux emplois directement dans votre mailbox?
Il n'y a actuellement aucune offre d'emploi. Suivez cette entreprise et nous vous informerons dès que de nouveaux emplois seront disponibles.